Proc Mixed FA0(1) for partial replicate [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2013-08-05 17:59 (3915 d 15:09 ago) – Posting: # 11206
Views: 8,771

Dear Wolfgang,

❝ For highly variable drugs, the reference-scaled average bioequivalence method is suggested by FDA. They request that a "conventional approach" analysis be done with some specific code, containing a random statement for SAS Proc Mixed,

random tmt / sub=subject type=FA0(2);

❝ But, in the case of a partially replicated design (RRT/RTR/TRR), this model is overspecified, which can lead to various error messages from SAS, to non-convergence, and to unstable results.


Welcome to the club. We had some discussions about that topic here in the forum.
Look here or here or here for instance. But no satisfactory solution.

❝ Has anyone thought about using type=FA0(1) instead? Which in this case amounts to the same model but correctly specified.


Interesting! Can you please a bit more specific:

❝ What would FDA's attitude be towards this?


Duno since never had that idea :-D. Also no experience with the FDA.
But I guess your proposal will be accepted if straight justified. The statisticians at FDA are those who :cool:.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
121 visitors (0 registered, 121 guests [including 3 identified bots]).
Forum time: 09:09 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5